| Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia J Tiihonen, E Mittendorfer-Rutz, M Majak, J Mehtälä, F Hoti, E Jedenius, ... JAMA psychiatry 74 (7), 686-693, 2017 | 682 | 2017 |
| Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors CU Correll, M Solmi, G Croatto, LK Schneider, SC Rohani‐Montez, ... World Psychiatry 21 (2), 248-271, 2022 | 397 | 2022 |
| 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20) H Taipale, A Tanskanen, J Mehtälä, P Vattulainen, CU Correll, J Tiihonen World psychiatry 19 (1), 61-68, 2020 | 370 | 2020 |
| Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia H Taipale, E Mittendorfer-Rutz, K Alexanderson, M Majak, J Mehtälä, ... Schizophrenia Research 197, 274-280, 2018 | 313 | 2018 |
| Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia J Tiihonen, H Taipale, J Mehtälä, P Vattulainen, CU Correll, A Tanskanen JAMA psychiatry 76 (5), 499-507, 2019 | 304 | 2019 |
| Nephrinuria in diabetic nephropathy of type 1 diabetes A Patari, C Forsblom, M Havana, H Taipale, PH Groop, H Holthofer, ... Diabetes 52 (12), 2969-2974, 2003 | 231 | 2003 |
| 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia J Tiihonen, A Tanskanen, H Taipale American Journal of Psychiatry 175 (8), 765-773, 2018 | 220 | 2018 |
| Comparative effectiveness of antipsychotic drugs for rehospitalization in schizophrenia—a nationwide study with 20-year follow-up H Taipale, J Mehtälä, A Tanskanen, J Tiihonen Schizophrenia bulletin 44 (6), 1381-1387, 2018 | 194 | 2018 |
| From prescription drug purchases to drug use periods–a second generation method (PRE2DUP) A Tanskanen, H Taipale, M Koponen, AM Tolppanen, S Hartikainen, ... BMC medical informatics and decision making 15, 1-13, 2015 | 194 | 2015 |
| Mortality in schizophrenia: 30‐year nationwide follow‐up study A Tanskanen, J Tiihonen, H Taipale Acta Psychiatrica Scandinavica 138 (6), 492-499, 2018 | 166 | 2018 |
| The clinical course of schizophrenia in women and men—a nation-wide cohort study IE Sommer, J Tiihonen, A van Mourik, A Tanskanen, H Taipale NPJ schizophrenia 6 (1), 12, 2020 | 163 | 2020 |
| Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder M Lähteenvuo, A Tanskanen, H Taipale, F Hoti, P Vattulainen, E Vieta, ... JAMA psychiatry 75 (4), 347-355, 2018 | 161 | 2018 |
| Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends M Sabe, T Pillinger, S Kaiser, C Chen, H Taipale, A Tanskanen, ... Neuroscience & Biobehavioral Reviews 136, 104608, 2022 | 136 | 2022 |
| Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer’s disease: a national population cohort study D Gnjidic, SN Hilmer, S Hartikainen, AM Tolppanen, H Taipale, ... PLoS one 9 (1), e83224, 2014 | 119 | 2014 |
| Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland H Taipale, M Solmi, M Lähteenvuo, A Tanskanen, CU Correll, J Tiihonen The Lancet Psychiatry 8 (10), 883-891, 2021 | 99 | 2021 |
| Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis JM Rubio, G Schoretsanitis, M John, J Tiihonen, H Taipale, D Guinart, ... The Lancet Psychiatry 7 (9), 749-761, 2020 | 97 | 2020 |
| Employment among people with schizophrenia or bipolar disorder: A population‐based study using nationwide registers M Holm, H Taipale, A Tanskanen, J Tiihonen, E Mitterdorfer‐Rutz Acta Psychiatrica Scandinavica 143 (1), 61-71, 2021 | 93 | 2021 |
| No association between proton pump inhibitor use and risk of Alzheimer’s disease H Taipale, AM Tolppanen, M Tiihonen, A Tanskanen, J Tiihonen, ... Official journal of the American College of Gastroenterology| ACG 112 (12 …, 2017 | 93 | 2017 |
| Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study AM Tolppanen, H Taipale, M Koponen, P Lavikainen, A Tanskanen, ... BMJ open 6 (7), e012100, 2016 | 92 | 2016 |
| High prevalence of psychotropic drug use among persons with and without Alzheimer׳ s disease in Finnish nationwide cohort H Taipale, M Koponen, A Tanskanen, AM Tolppanen, J Tiihonen, ... European Neuropsychopharmacology 24 (11), 1729-1737, 2014 | 89 | 2014 |
